Skip to main content
. Author manuscript; available in PMC: 2009 May 4.
Published in final edited form as: Langmuir. 2008 Jul 15;24(16):9162–9171. doi: 10.1021/la703854x

Table 5.

Quenching Efficiencies and Coverages for Beacons Undergoing Post-Assembly Treatmenta or No Post-Assembly Treatment b

post-treatment no post-treatment
beacons Quenching efficiency (%) coverage (/cm2) quenching Efficiency (%) coverage (/cm2)
DENV-2 95 ± 1 6.3 × 1012 95 ± 1 6.9 × 1012
HIV 82 ± 2 6.4 × 1012 87 ± 2 5.8 × 1012
INF B 91 ± 1 4.8 × 1012 93 ± 2 5.8 × 1012
HCV − − 77 ± 6 1.2 × 1013
SARS − − 86 ± 2 4.2 × 1012
a

Postassembly treatment procedure entails nanowire-DNA reaction overnight in 0.01 M PBS with a 2 h aging step in 0.3 M PBS.

b

No post-treatment assembly entails reaction in only 0.3 M PBS for 25 min.